Today: 12 December 2025
Subscribe
Browse Category

Company News News 20 November 2025 - 22 November 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025

Telomir Pharmaceuticals (NASDAQ: TELO) shares react to new preclinical leukemia data and a director resignation on November 21, 2025. Here’s what today’s Telomir-1 news means for TELO stock and investors. What happened to Telomir Pharmaceuticals (TELO) today? On Friday, November
21 November 2025
 ·  ·  ·  ·  · 
Macquarie Group (ASX: MQG): What to Know Before the ASX Opens on 17 November 2025

Macquarie Group (ASX: MQG) reshuffles resources bets as it builds stakes in Service Stream and Monadelphous, exits Sandfire Resources

Published: 20 November 2025 – All figures in Australian dollars unless stated otherwise. Macquarie Group Ltd (ASX: MQG) has quietly made a series of eye‑catching moves on the ASX this week, lifting its exposure to infrastructure and engineering services while
21 November 2025
 ·  ·  ·  · 
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Stock Today (November 20, 2025): Price Slides After AI Rally as IRAP Win, New U.S. Army Deal and Analyst Split Shape the Story

Updated: November 20, 2025 Palantir Technologies (NASDAQ: PLTR) remains at the center of the artificial intelligence (AI) trade — but today’s action shows just how volatile that trade has become. After touching all‑time highs earlier this month, Palantir stock has
20 November 2025
 ·  ·  ·  ·  · 
Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions Inc. (NYSE: J) kicked off Thursday’s trading session with a flurry of news: stronger‑than‑expected fiscal fourth‑quarter 2025 results, a bullish 2026 earnings outlook, fresh SEC filings, and continued shareholder returns via dividends and buybacks. The engineering and professional
20 November 2025
 ·  ·  ·  ·  · 
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Stock Today (November 20, 2025): Wegovy Price Cuts, Alzheimer’s ‘Lottery Ticket’ Trials and Denmark GDP Put NVO Back in the Spotlight

Novo Nordisk stock is back on traders’ screens today as a cluster of fresh headlines – from high‑stakes Alzheimer’s trials to aggressive Wegovy price cuts and new Danish GDP data – reshapes the narrative around the Ozempic maker. On Thursday,
20 November 2025
 ·  ·  ·  ·  · 
British American Tobacco (LSE: BATS) share price: what to know before the London open on 17 November 2025

British American Tobacco Share Price Today, 20 November 2025: BATS Extends 43% 12‑Month Rally on Buybacks and Insider Buying

London – 20 November 2025 British American Tobacco’s London‑listed shares continued their strong 2025 run today, edging higher as the group’s ongoing share buyback programme, fresh insider share purchases and new institutional interest underpinned sentiment toward the FTSE 100 tobacco
20 November 2025
 ·  ·  ·  ·  · 
1 … 25 26 27 28 29 … 42
Go toTop